Pill may free babies with rare diabetes from daily insulin shots
NCT ID NCT00610038
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether babies with a rare, permanent form of diabetes caused by specific gene changes could switch from daily insulin injections to an oral pill called glibenclamide. Nineteen infants took part. The goal was to see if the pill could control their blood sugar and possibly improve their development, while avoiding the need for lifelong insulin.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Necker Hospital - Endocrinology Gynecology Pediatric unit
Paris, 75015, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Quitting smoking may also ward off diabetes — a trial puts the dual strategy to the test
- Could a simple clinic Check-In change catch hidden high blood pressure and diabetes?
- Decades-Long study of 121,700 nurses aims to uncover hidden heart disease triggers
- Could donating blood help control diabetes and fatty liver?
- Phone-Based fitness program aims to cut heart disease in african american women
- Could a wearable sensor replace Finger-Sticks for hospital diabetes care?